Herriot Tabuteau sold $12M of AXSM stock

Herriot Tabuteau, Chief Executive Officer, 10% of Axsome Therapeutics, Inc. (AXSM), sold 49,670 shares of AXSM stock worth $12M, per an SEC Form 4 filed Jun 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Jun 9, 2026.

AXSM has moved -42.3% since the trade date, from $245.64 to $141.69 (Nov 13, 2026 close).